Botulinum toxin A as a treatment modality for acute acquired comitant esotropia – An Indian perspective
Purpose: To analyze the outcomes of botulinum toxin A injection in acute acquired comitant esotropia (AACE). Methods: This is a retrospective study that included cases diagnosed as AACE between January 2022 and February 2023. Patients who were treated with Botox and completed a minimum 3 months foll...
Saved in:
| Main Authors: | Akshay Badakere, Vibha Badrinath, Hennaav Kaur Dhillon, Abinaya Valliappan, Viswanathan Natarajan, Sumita Agarkar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-02-01
|
| Series: | Indian Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/IJO.IJO_2198_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of botulinum toxin and surgery in managing acute acquired comitant esotropia
by: Xiangxiang Liu, et al.
Published: (2025-04-01) -
Botulinum toxin-A in acute acquired comitant esotropia during COVID pandemic in children and young adolescents
by: Neelam Pawar, et al.
Published: (2025-02-01) -
Acute acquired comitant esotropia: Current understanding of its etiological classification and treatment strategies
by: Noriko Nishikawa, et al.
Published: (2025-01-01) -
Effectiveness of treatment modalities for childhood esotropia: a systematic review
by: Saif Hassan Alrasheed, et al.
Published: (2025-06-01) -
Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice
by: R. K. Shikhkerimov, et al.
Published: (2022-12-01)